Correlation Between CTT Pharmaceutical and Dakshidin

Can any of the company-specific risk be diversified away by investing in both CTT Pharmaceutical and Dakshidin at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CTT Pharmaceutical and Dakshidin into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between CTT Pharmaceutical Holdings and Dakshidin Corporation, you can compare the effects of market volatilities on CTT Pharmaceutical and Dakshidin and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CTT Pharmaceutical with a short position of Dakshidin. Check out your portfolio center. Please also check ongoing floating volatility patterns of CTT Pharmaceutical and Dakshidin.

Diversification Opportunities for CTT Pharmaceutical and Dakshidin

-0.05

Correlation Coefficient

CTT Pharmaceutical  Dakshidin

Good diversification

The 3 months correlation between CTT and Dakshidin is -0.05. Overlapping area represents the amount of risk that can be diversified away by holding CTT Pharmaceutical Holdings and Dakshidin Corp. in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dakshidin and CTT Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CTT Pharmaceutical Holdings are associated (or correlated) with Dakshidin. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dakshidin has no effect on the direction of CTT Pharmaceutical i.e., CTT Pharmaceutical and Dakshidin go up and down completely randomly.

Pair Corralation between CTT Pharmaceutical and Dakshidin

Given the investment horizon of 90 days CTT Pharmaceutical is expected to generate 15.41 times less return on investment than Dakshidin. But when comparing it to its historical volatility, CTT Pharmaceutical Holdings is 1.3 times less risky than Dakshidin. It trades about 0.0 of its potential returns per unit of risk. Dakshidin Corporation is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  0.10  in Dakshidin Corporation on October 6, 2024 and sell it today you would earn a total of  0.00  from holding Dakshidin Corporation or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	95.35%
Values	Daily Returns

CTT Pharmaceutical Holdings  vs.  Dakshidin Corp.

CTT Pharmaceutical

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in CTT Pharmaceutical Holdings are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite fairly unsteady basic indicators, CTT Pharmaceutical may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Dakshidin

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Dakshidin Corporation are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, Dakshidin exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with CTT Pharmaceutical and Dakshidin

The main advantage of trading using opposite CTT Pharmaceutical and Dakshidin positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CTT Pharmaceutical position performs unexpectedly, Dakshidin can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dakshidin will offset losses from the drop in Dakshidin's long position.

The idea behind CTT Pharmaceutical Holdings and Dakshidin Corporation pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.